1. A Perspective on Emerging Therapeutic Interventions for COVID-19
   Muhammad Torequl Islam et al, 2020, Front. Public Health CrossRef
2. Physicians’ Perspectives on COVID-19: An International Survey
   Alina Dima et al, 2020, Healthcare CrossRef
3. The Under-Reported Role of Toxic Substance Exposures in the COVID-19 Pandemic
   Ronald N. Kostoff et al, 2020, Food and Chemical Toxicology CrossRef
4. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
   Aikaterini Nasi et al, 2020, Toxicology Reports CrossRef
5. Probiotics: Versatile Bioactive Components in Promoting Human Health
   Javad Sharifi-Rad et al, 2020, Medicina CrossRef
6. COVID-19 vaccines: ethical framework concerning human challenge studies
   Daniela Calina et al, 2020, DARU J Pharm Sci CrossRef
7. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
   Raymond Chang et al, 2020, Int J Antimicrob Agents CrossRef
8. The Natural-Mineral-Based Novel Nanomaterial IFMC Increases Intravascular Nitric Oxide without Its Intake: Implications for COVID-19 and beyond
   Tomohiro Akiyama et al, 2020, Nanomaterials CrossRef
9. Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
   Jorge Morales-Torres et al, 2020, Clin Rheumatol CrossRef
10. Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
    Chandan Sarkar et al, 2020, Front. Pharmacol. CrossRef
11. SARS-CoV-2 vaccine development: An overview and perspectives
    Yi Liu et al, 2020, ACS Pharmacol. Transl. Sci. CrossRef
12. A brief outlook on the current emerging trends of COVID 19 vaccines
    Smitha Thammaiaha et al, 2020, J Oral Maxillofac Pathol CrossRef
13. Unraveling the Possible Routes of SARS-COV-2 Invasion into the Central Nervous System
    Maria Lima et al, 2020, Curr Treat Options Neurol CrossRef
14. The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
    Soheila Molaei et al, 2020, International Immunopharmacology CrossRef
15. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
    Aristides Tsatsakis et al, 2020, Food and Chemical Toxicology CrossRef
16. Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
    Daniela Calina et al, 2020, Immunol Res CrossRef
17. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening
    Cristina Adriana Dehelean et al, 2020, JCM CrossRef
18. Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action
    Javad Sharifi-Rad et al, 2020, Front. Pharmacol. CrossRef
19. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety
    Ronald N. Kostoff et al, 2020, Toxicology Reports CrossRef
20. Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence
    Naveen Vankadari et al, 2020, J. Phys. Chem. Lett. CrossRef
21. COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines.
    Rémi Labetoulle et al, 2020, Expert Review of Vaccines CrossRef
22. The dangers of performative scientism as the alternative to anti-scientific policymaking: A critical, preliminary assessment of South Africa’s Covid-19 response and its consequences
    Seán M. Muller, 2020, World Development CrossRef
23. An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting
    Noemi Lopes et al, 2020, Front. Public Health CrossRef
24. One Year Update on the COVID-19 Pandemic: Where Are We Now?
    Sanjay Kumar Mishra et al, 2020, Acta Tropica CrossRef
25. Why METH users are at high risk of fatality due to COVID-19 infection?
    Md Kamal Hossain et al, 2020, Expert Review of Vaccines CrossRef
26. COVID-19 in the elderly people and advances in vaccination approaches
    Kuldeep Dhama et al, 2020, Human Vaccines & Immunotherapeutics CrossRef
27. Nicotinic Cholinergic System and COVID-19: In Silico Evaluation of Nicotinic Acetylcholine Receptor Agonists as Potential Therapeutic Interventions
    Nikolaos Alexandris et al, 2020, Toxicology Reports CrossRef
28. THROMBOSIS AND HAEMOSTASIS CHALLENGES IN COVID-19 – THERAPEUTIC PERSPECTIVES OF HEPARIN AND TISSUE-TYPE PLASMINOGEN ACTIVATOR AND POTENTIAL TOXICOLOGICAL REACTIONS-A MINI REVIEW
    Laura Mazilu et al, 2021, Food and Chemical Toxicology CrossRef
29. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19.
    Muhammad Torequl Islam et al, 2021, Int J Vitam Nutr Res CrossRef
30. Immune response scenario and vaccine development for SARS-CoV-2 infection
    Mai H.S. Mohammad, 2021, International Immunopharmacology CrossRef
31. Maternal Vaccines - Safety in pregnancy
    Mala Arora et al, 2021, Best Practice & Research Clinical Obstetrics & Gynaecology CrossRef
32. An overview of vaccine development for COVID-19
    Seyed H Shahcheraghi et al, 2021, Therapeutic Delivery CrossRef
33. The find of COVID-19 vaccine: Challenges and opportunities
    Marwan ElBagoury et al, 2021, Journal of Infection and Public Health CrossRef
34. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
    Malik Sallam, 2021, Vaccines CrossRef
35. COVID‐19 into Chemical Science Perspective: Chemical Preventive Measures and Drug Development
    Bimalendu Adhikari et al, 2021, ChemistrySelect CrossRef
36. COVID-19 pandemic and alcohol consumption: impacts and interconnections
    Daniela Calina et al, 2021, Toxicology Reports CrossRef
37. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
    George Nitulescu et al, 2020, Int J Mol Med CrossRef
38. Back to basics in COVID‐19: Antigens and antibodies—Completing the puzzle
    Monica Neagu et al, 2021, J Cell Mol Med CrossRef
39. Keeping governments accountable: the COVID-19 Assessment Scorecard (COVID-SCORE)
    Jeffrey V. Lazarus et al, 2020, Nat Med CrossRef
40. [Editorial] COVID‑19: Post‑lockdown guidelines
    Ronald Kostoff et al, 2020, Int J Mol Med CrossRef
41. A dissection of SARS‑CoV2 with clinical implications (Review)
    Felician Stancioiu et al, 2020, Int J Mol Med CrossRef
42. COVID-19 Vaccine Challenges: What have we learned so far and what remains to be done?
    Rebecca Forman et al, 2021, Health Policy CrossRef
43. Research, Development and Application of COVID-19 Vaccines: Progress, Challenges, and Prospects
    Gong Feng et al, 2021 CrossRef
44. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy.
    Marco Vinceti, 0 CrossRef
45. Safety of COVID-19 vaccines administered in the EU: Should we be concerned?
    Antonio F. Hernández et al, 2021, Toxicology Reports CrossRef
46. Flavonoids are promising safe therapy against COVID-19
    Moza Mohamed Alzaabi et al, 2021, Phytochem Rev CrossRef
47. Identifying US County-level characteristics associated with high COVID-19 burden
    Daniel Li et al, 2021, BMC Public Health CrossRef
48. COVID‐19 vaccines and nanomedicine
    Robert S. Shapiro, 2021, Int J Dermatol CrossRef
49. Protective Action of L. salivarius SGL03 and Lactoferrin against COVID-19 Infections in Human Nasopharynx
    Marzena Kucia et al, 2021, Materials CrossRef
50. Epitope-Specific Response of Human Milk Immunoglobulins in COVID-19 Recovered Women
    Tatyana V. Bobik et al, 2021, Pathogens CrossRef
51. SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
    Shuo Ning et al, 2021, Front. Cell. Infect. Microbiol. CrossRef
52. Challenges of COVID-19 and Tuberculosis - Urgent Need to Tackle the Dual Burden
    Karma Gurmey Dolma et al, 2021, jemds CrossRef
53. Next-Generation Bioinformatics Approaches and Resources for Coronavirus Vaccine Discovery and Development—A Perspective Review
    Rahul Chatterjee et al, 2021, Vaccines CrossRef
54. An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
    Anne-Catherine Fluckiger et al, 2021, Vaccine CrossRef
55. Silencing of long non-coding RNA KCNQ1OT1 alleviates LPS-induced lung injury by regulating the miR-370-3p/FOXM1 axis in childhood pneumonia
    Ping Wang et al, 2021, BMC Pulm Med CrossRef
56. Disproportionate coronavirus disease 2019 (COVID-19) vaccine distribution—A great threat to low- and middle-income countries
    Prashant Upadhyay et al, 2021, Infect. Control Hosp. Epidemiol. CrossRef
57. A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development
    Rasmita DASH et al, 2021, Minerva Biotechnol Biomol Res CrossRef
58. A comprehensive insight on the COVID-19 vaccine candidates
    Anu Sharma et al, 2021, J Family Med Prim Care CrossRef
59. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
    Lei Li et al, 2021, Vaccine CrossRef
60. University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study
    Madeleine Mant et al, 2021, PLoS ONE CrossRef
61. Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review
    Maryam Sharifian-Dorche et al, 2021, Journal of the Neurological Sciences CrossRef
62. Perspectives of dermatology specialists and residents on COVID‐19 vaccines: A questionnaire‐based survey
    Efsun Tanacan et al, 2021, Int J Clin Pract CrossRef
63. null
    Ronald N. Kostoff et al, 2021 CrossRef
64. null
    Taxiarchis Konstantinos Nikolouzakis et al, 2021 CrossRef
65. An in silico scientific basis for LL-37 as a therapeutic for Covid-19.
    Kiran Bharat Lokhande et al, 2022, Proteins CrossRef
66. Reporting at Least One Adverse Effect Post-COVID-19 Vaccination From Primary Health Care in Muscat
    Thamra S Al Ghafri et al, 2021 CrossRef
67. Guillain‑Barré syndrome associated with Covid‑19: A close relationship or just a coincidence? (Review)
    Adina Stoian et al, 2021, Exp Ther Med CrossRef
68. Professional ethics, VBAC and COVID‑19 pandemic: A challenge to be resolved (Review)
    Alexandru Carauleanu et al, 2021, Exp Ther Med CrossRef
69. Immune thrombocytopenia, severe hematological consequence in a patient with COVID‑19: A case report
    Oana-Viola Badulescu et al, 2021, Exp Ther Med CrossRef
70. Challenges and Progress in Vaccine Development for COVID-19 Coronavirus (SARS-CoV-2): A Review
    Keshav S. Moharir et al, 2021, TOCOVIDJ CrossRef
71. Biopharmaceutics 4.0, Advanced Pre-Clinical Development of mRNA-Encoded Monoclonal Antibodies to Immunosuppressed Murine Models
    Andreas Ouranidis et al, 2021, Vaccines CrossRef
72. SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
    Hadis Fathizadeh et al, 2021, International Journal of Biological Macromolecules CrossRef
73. Vaccine Design and Delivery Approaches for COVID-19
    Kiana Shahzamani et al, 2021, International Immunopharmacology CrossRef
74. Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action
    Javad Sharifi-Rad et al, 2021, Front. Pharmacol. CrossRef
75. Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2.
    Siya Kamat et al, 2021, J Control Release CrossRef
76. COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria
    Obi Peter Adigwe, 2021, Vaccine: X CrossRef
77. High‑dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS‑CoV‑2 infection: A case‑based review of the literature (Review)
    Adina Stoian et al, 2021, Exp Ther Med CrossRef
78. Why are We Vaccinating Children against COVID-19?
    Ronald N. Kostoff et al, 2021, Toxicology Reports CrossRef
79. COVID-19: A HEALTH PERSPECTIVE
    SHEENA WONG et al, 2021, J. Bus. Econ. A. CrossRef
80. Discovery of potential SARS-CoV 3CL protease inhibitors from approved antiviral drugs using: virtual screening, molecular docking, pharmacophore mapping evaluation and dynamics simulation
    Ismail Daoud et al, 2021, Journal of Biomolecular Structure and Dynamics CrossRef
81. Understanding the Last Mile Transportation Concept Impacting Underserved Global Communities to Save Lives During COVID-19 Pandemic
    Erick C. Jones et al, 2021, Front. Future Transp. CrossRef
82. COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19
    Simon N. Mbugua et al, 2021, Journal of Chemistry CrossRef
83. Effect of gentle exercises on injection site reaction after Covid-19 vaccination. A case report
    Varun Kalia, 2021, Journal of Bodywork and Movement Therapies CrossRef
84. Tracking the progress in COVID-19 and vaccine safety research – a comprehensive bibliometric analysis of publications indexed in Scopus database
    Tosin Yinka Akintunde et al, 2021, Human Vaccines & Immunotherapeutics CrossRef
85. Attitudes of Healthcare Professionals and General Population Toward Vaccines and the Intention to Be Vaccinated Against COVID-19 in Spain
    Isabel Iguacel et al, 2021, Front. Public Health CrossRef
86. Impact of COVID‑19 prevention measures on Clostridioides difficile infections in a regional acute care hospital
    Simona Sipos et al, 2021, Exp Ther Med CrossRef
87. Prediction of in‑hospital recurrence and false‑negative results in patients with COVID‑19 by red blood cell values on admission
    Xue Jiang et al, 2021, Exp Ther Med CrossRef
88. Extracorporeal membrane oxygenation in the management of critically ill patients with coronavirus disease 2019: A narrative review
    Alexandru Pleșoianu et al, 2021, Exp Ther Med CrossRef
89. Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena
    Vivek P. Chavda et al, 2021, Biologics CrossRef
90. Lung ultrasound in predicting COVID‐19 clinical outcomes: A prospective observational study
    Mojtaba Chardoli et al, 2021, Journal of the American College of Emergency Physicians Open CrossRef
91. Policy Stringency, Handwashing and COVID-19 cases: Evidence from Global dataset
    Janet Dzator et al, 2021, Health Policy and Technology CrossRef
92. Association between COVID-19 Vaccine Side Effects and Body Mass Index in Spain
    Isabel Iguacel et al, 2021, Vaccines CrossRef
93. Haematological malignancies implications during the times of the COVID‑19 pandemic (Review)
    Eleni Papakonstantinou et al, 2021, Oncol Lett CrossRef
94. Demographic, anthropometric, and metabolic characteristics of obstructive sleep apnea patients from Romania before the COVID‑19 pandemic
    Adriana Neagos et al, 2021, Exp Ther Med CrossRef
95. In Silico Screening of Natural Products as Potential Inhibitors of SARS-CoV-2 Using Molecular Docking Simulation
    Rajib Hossain et al, 2021, Chin. J. Integr. Med. CrossRef
96. Comparative analysis of existing platforms for the development of vaccines against dangerous and extremely dangerous viral infections with pandemic potential
    G. G. Onishchenko et al, 2021, Biopreparaty. Profilaktika, diagnostika, lechenie CrossRef
97. The race for a COVID-19 vaccine: where are we up to?
    Md Kamal Hossain et al, 2021, Expert Review of Vaccines CrossRef
98. Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review).
    Vasiliki Efstathiou et al, 2022, Exp Ther Med CrossRef
99. Acute kidney injury in moderate and severe COVID‑19 patients: Report of two university hospitals
    Daniela Radulescu et al, 2021, Exp Ther Med CrossRef
100. Diagnostic challenges, management, and outcome of infants born to mothers with COVID 19 during the first wave of the pandemic
     Gabriela Zaharie et al, 2021, Exp Ther Med CrossRef
101. Therapeutic plasma exchange followed by convalescent plasma transfusion in severe and critically ill COVID‑19 patients: A single centre non‑randomized controlled trial
     Alexandru Novacescu et al, 2021, Exp Ther Med CrossRef
102. DNA vaccines against COVID-19: Perspectives and challenges
     Marcelle Moura Silveira et al, 2021, Life Sciences CrossRef
103. The role of nursing professionals and challenges encountered in the effective containment of the ongoing COVID-19 pandemic
     SaurabhRamBihariLal Shrivastava et al, 2021, Acta Med Int CrossRef
104. Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study
     Sourav Das et al, 2022, Biologia CrossRef
105. Clinical and statistical assessment of the reproductive health of fertilized women in the Tyumen region and the risks of miscarriage in Western Siberia
     E. A. Mateykovich et al, 2022, Medicinskij sovet CrossRef
106. Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID‑19
     Dina Abdelhakam et al, 2021, Biomed Rep CrossRef
107. Forecasting the COVID-19 vaccine uptake rate: an infodemiological study in the US
     Xingzuo Zhou et al, 2022, Human Vaccines & Immunotherapeutics CrossRef
108. Global landscape of COVID-19 vaccination progress: insight from an exploratory data analysis
     Samrat Kumar Dey et al, 2022, Human Vaccines & Immunotherapeutics CrossRef
109. An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients
     Micah Skeens et al, 2022, Bone Marrow Transplant CrossRef
110. Covid-19 vaccine acceptance and associated factors among pregnant women in Pennsylvania 2020
     Kristin K. Sznajder et al, 2022, Preventive Medicine Reports CrossRef
111. Bacterial endocarditis masked by COVID‑19: A case report
     Mircea Bajdechi et al, 2021, Exp Ther Med CrossRef
112. Treatment of patients with Covid‑19 with a high dose of ulinastatin
     Hai Huang et al, 2021, Exp Ther Med CrossRef
113. Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey
     Z.A. Khan et al, 2021, Vacunas CrossRef
114. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
     Rikin Patel et al, 2022, Human Vaccines & Immunotherapeutics CrossRef
115. COVID-19 Vaccine Hesitancy among Health Workers in Surgical Departments in Port Harcourt, Nigeria
     Promise N.W. et al, 2022, African Journal of Biology and Medical Research CrossRef
116. COVID-19 vaccines: a look at the ethics of the clinical research involving children
     Laura Cabiedes-Miragaya et al, 2022, J Med Ethics CrossRef
117. Bi-objective Optimization for a Multi-period COVID-19 Vaccination Planning Problem
     Lianhua Tang et al, 2022, Omega CrossRef
118. An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
     Kairat Tabynov et al, 2022, npj Vaccines CrossRef
119. A Data-Driven Robust Optimization Model by Cutting Hyperplanes on Vaccine Access Uncertainty in COVID-19 Vaccine Supply Chain
     Hani Gilani et al, 2022, Omega CrossRef
120. Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching
     Vivencio O. Ballano, 2022, Linacre Q CrossRef
121. COVID-19 Vaccination Among the Arab Bedouin Population: Lessons Learned From a Minority Population
     Naim Abu-Freha et al, 2022, Int J Public Health CrossRef
122. Perceived Vaccine Efficacy, Willingness to Pay for COVID-19 Vaccine and Associated Determinants among Foreign Migrants in China
     Tosin Yinka Akintunde et al, 2022, ELECTRON J GEN MED CrossRef
123. COVID-19 vaccine candidates: A review
     Martyna Biała et al, 2021 CrossRef
124. SARS‑CoV‑2 infection and children: Insights from the 6th Workshop on Paediatric Virology (Review)
     Ioannis Mammas et al, 2022, World Acad Sci J CrossRef
125. Clinical characteristics of patients with acute ischemic stroke previously vaccinated against COVID-19
     Marija Stamenković et al, 2022, Journal of Stroke and Cerebrovascular Diseases CrossRef
126. Participation of Religious Leaders in Helping the Success of the Government's COVID-19 Vaccination Program
     Simon Simon et al, 2021, EJTI CrossRef
127. Analyzing the factors that will impact the supply chain of the COVID-19 vaccine: A structural equation modeling approach
     Subhodeep Mukherjee et al, 2022, Journal of Statistics and Management Systems CrossRef
128. Multiple evanescent white dot syndrome following BNT162b2 mRNA COVID-19 vaccination
     Eriko Yasuda et al, 2022, American Journal of Ophthalmology Case Reports CrossRef
129. Determinants of Covid-19 Vaccine Acceptance among Students: A Web-Based Global Survey
     S. Fatima Irfan et al, 2022, EJMED CrossRef
130. Pregnancy outcomes and thyroid dysfunction: preterm birth risk assessment
     E. A. Mateykovich et al, 2022, Medicinskij sovet CrossRef
131. Rupture of Vertebral Artery Dissecting Aneurysm after mRNA Anti-COVID-19 Vaccination: A Report of Two Cases
     Kohei CHIDA et al, 2022 CrossRef
132. null
     Mahyar Kolivand et al, 2022 CrossRef
133. COVID-19 management landscape- A need for an affordable to manufacture safe and efficacious bio-therapeutic and prophylactic for developing countries
     Vyankatesh Pidiyar et al, 2022, Vaccine CrossRef
134. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro
     Pallavi More-Adate et al, 2022, Computers in Biology and Medicine CrossRef
135. null
     Mouraya Hussein et al, 2022 CrossRef
136. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
     Ameneh Jafari et al, 2022, Mol Biol Rep CrossRef
137. Exploring the Chinese Public’s Perception of Omicron Variants on Social Media: LDA-Based Topic Modeling and Sentiment Analysis
     Han Wang et al, 2022, IJERPH CrossRef
138. A RECENT REVIEW ON: CORONAVIRUS DISEASE 2019
     MANDEEP SINGH et al, 2022, Asian J Pharm Clin Res CrossRef
139. COVID-19 vaccine uptake and associated factors among pregnant women attending antenatal care in Debre Tabor public health institutions: A cross-sectional study
     Endeshaw Chekol Abebe et al, 2022, Front. Public Health CrossRef
140. New onset of acute uveitis following COVID-19 vaccination
     Ha Eun Sim et al, 2022, Graefes Arch Clin Exp Ophthalmol CrossRef
141. Antibodies in the breastmilk of COVID-19 recovered women
     Paulina Szczygioł et al, 2022, BMC Pregnancy Childbirth CrossRef
142. COVID-19 and vaccination: myths vs science
     Vivek P. Chavda et al, 2022, Expert Review of Vaccines CrossRef
143. Analysis of Double-Chain Deoxyribonucleic Acid Dynamical System in Pandemic Confrontation
     Shao-Wen Yao et al, 2022, Results in Physics CrossRef
144. The impact factors of social media users' forwarding behavior of COVID-19 vaccine topic: Based on empirical analysis of Chinese Weibo users
     Kun Sun et al, 2022, Front. Public Health CrossRef
145. COVID-19 Vaccinating Russian Medical Students—Challenges and Solutions: A Cross-Sectional Study
     Olesya V. Kytko et al, 2022, IJERPH CrossRef
146. Assessment of attitude and hesitancy toward vaccine against COVID-19 in a Pakistani population: A mix methods survey
     Z.A. Khan et al, 2022, Vacunas (English Edition) CrossRef
147. Factors Associated with Vaccination Intention against the COVID-19 Pandemic: A Global Population-Based Study
     Junjie Huang et al, 2022, Vaccines CrossRef
148. Towards the development of an epitope-focused vaccine for SARS-CoV-2
     Jacquelynne Cervantes-Torres et al, 2022, Vaccine CrossRef
149. Predictors of COVID-19 Vaccine Acceptability among Patients Living with HIV in Northern Nigeria: A Mixed Methods Study
     Zubairu Iliyasu et al, 2022, CHR CrossRef
150. Lateral Flow Immunoassay Reader Technologies for Quantitative Point-of-Care Testing
     Jongwon Park, 2022, Sensors CrossRef
151. null
     Oxford York et al, 2022 CrossRef
152. Perceived COVID-19 vaccine attributes associated with early adoption among adults in rural Indiana
     Kristina Hunter-Mullis et al, 2022 CrossRef
153. An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
     Nikita N. Kostin et al, 2022, Acta Naturae CrossRef
154. null
     Vivencio O. Ballano, 2022 CrossRef
155. Hesitation about coronavirus vaccines in healthcare professionals and general population in Spain
     Francesc Saigí-Rubió et al, 2022, PLoS ONE CrossRef
156. COVID-19 Vaccines, Effectiveness, and Immune Responses
     Haneen Imad Abufares et al, 2022, IJMS CrossRef
157. Análisis in silico de la inmunogenicidad e interacción molecular de péptidos de plantas aromáticas con SARS-CoV-2
     Andrea Lorena Delgado-Betancourt et al, 2022, RVACCB CrossRef
158. Rough Set: Utilizing Machine Learning for the Covid-19 Vaccine
     Silfia Andini et al, 2022, J. Phys.: Conf. Ser. CrossRef
159. SARS-CoV-2 antibody response after BBIBP-CorV (Sinopharm) vaccination in cancer patients: A case-control study
     Fahimeh Safarnezhad Tameshkel et al, 2023, Front. Med. CrossRef
160. null
     Katharine C. Carter et al, 2022 CrossRef
161. Anti-SARS-CoV-2 spike receptor binding domain (S-RBD) IgG antibodies following CoronaVac administration: a longitudinal study. Anti-SARS-CoV-2 S-RBD IgG antibodies
     Ph. Liana et al, 2023, Med. immunol. CrossRef
162. Analyzing the Morality of Owning and Suspending Patent Rights for COVID-19 Vaccines in the Light of Catholic Social Teaching
     Vivencio Ballano, 2021, SSRN Journal CrossRef
163. Acute disseminated encephalomyelitis (ADEM) following COVID-19 vaccination: A systematic review
     Fardin Nabizadeh et al, 2023, Journal of Clinical Neuroscience CrossRef